Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Buy rating for Select Medical Holdings (NYSE:SEM) and maintained a price target of $48.
November 01, 2024 | 2:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland has reiterated a Buy rating for Select Medical Holdings and maintained a price target of $48, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $48 price target by a reputable analyst suggests a positive outlook for Select Medical Holdings. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100